Type 2 Diabetes: Rosenstock et al., 2023 (Lancet) Rosenstock, Fras, Jastreboff, and colleagues reported a phase 2, randomized, double-blind, placebo- and active-controlled, parallel-group trial in The Lancet in 2023 [5]
Control, Variability, and What Can Change Willows program divides control across the platform, external clinicians, and outside pharmacies, which explains why pricing details, medication access, and timing are not fixed or uniform
Stop taking the medication immediately and call your physician
Hence, DPP4 inhibition likely mediates cardioprotection indirectly through one or more substrates in vivo
Three weeks of six days per week high intensity resistance training increased oxidative stress in blood as indicated by serum thiobarbituric acid-reacting substances (TBARS), which is an indicator of lipid peroxidation, by 56% while reducing whole blood total glutathione content (GSH) by 31% (an endogenous antioxidant), and total antioxidant capacity (TAC) by 20% [11]
Baseline labs often include fasting glucose, A1C, lipid panels, and sometimes inflammatory markers